Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-12 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-12 |
mRNA | ZNF606 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-11 |
mRNA | CELF4 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
mRNA | ZNF302 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-11 |
mRNA | RP3-403A15.5 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | CTC-398G3.6 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | BEND5 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
mRNA | KCNC1 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |